ArticleJournal of cellular and molecular medicine2019

Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell.

Yibing Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.